'Fingerprinting' individual human cells

Wednesday, 18 December, 2019

'Fingerprinting' individual human cells

By combining single-cell analysis techniques with machine learning algorithms, a team led by the Garvan Institute of Medical Research has developed a method to ‘fingerprint’ human cells. The method, called ‘scPred’ and published in the journal Genome Biology, has the potential to allow earlier detection of cancer, identify the cells at the root of autoimmune disease and help personalise treatments to individual patients.

The study was led by Associate Professor Joseph Powell, Director of The Garvan-Weizmann Centre for Cellular Genomics. He explained, “For a long time we’ve mainly classified different cells in the human body based on a limited number of markers found on the cell surface or inside the cell. What we’re learning now is that underneath one ‘type’, there is a huge diversity of different cell types — for instance, even though different cancer cells could all have the same cell surface markers, only a subgroup of those cells may actually form a metastatic tumour.”

The researchers developed a new method of analysing transcripts of individual cells — a measure of which genes are active in different cells, which provides extensive information of what makes cells unique. scPred thus solves the challenge of determining what within the vast amounts of generated transcript data can provide the most useful information that defines a cell type.

“Our scPred method first collapses all the transcript data from a single cell — instead of trying to estimate 20,000 things at once, it works out which patterns of those 20,000 have the most predictive power in distinguishing one cell type from another cell type,” said José Alquicira-Hernández, a PhD student at The University of Queensland and first author on the study.

scPred then ‘trains’ a statistical model on those patterns to test what features make a certain cell type ‘most different’ from another cell — which can be thought of as a unique fingerprint,” Alquicira-Hernández continued. Once a certain cell type has been ‘fingerprinted’, researchers can use the trained model to look for that same cell type in any other sample, in datasets from anywhere in the world.

The researchers have validated the approach using datasets of colorectal cancer cells analysed by collaborators at Stanford University, successfully using scPred models to identify cancer cells from a tissue sample with over 98% accuracy. The researchers say their method adds enormous improvements in the resolution of cell types, and may uncover diseased cells that are outside the scope of current medical diagnostics.

Thanks to single-cell sequencing methods, scientists can take snapshots of over 20,000 different pieces of information in a single cell’s transcript, and can do so for tens of thousands of cells at a time; scPred opens the technology to diagnostic applications for the first time. Through The Garvan-Weizmann Centre for Cellular Genomics, the researchers are now moving to the next phase of translating the method to accredited tests for clinical practice.

“Our scPred method gives us the possibility of earlier detection; it may allow us to determine the stage of a cancer patient, what potential drugs they will respond to or whether their tumour cells have signatures that indicate resistance to chemotherapy,” Assoc Prof Powell said. “The potential for this new method is enormous.”

Image credit: ©stock.adobe.com/au/Ivanc7

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Biomarkers in urine can determine asthma subtypes

Researchers have used a urine test to identify and verify a patient's type of asthma, laying...

New COVID-19 RNA test returns results in minutes

UK researchers have invented a COVID-19 test that is said to reduce testing time from 30 minutes...

Rapid COVID-19 tests to be rolled out in Africa

The rollout of new, World Health Organization-approved, antigen-based rapid diagnostic tests for...

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd